🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to collect data about how 18FPARPi can be used together with ...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2019-11-01
Trial ID
NCT04173104
Treatments Being Tested
The primary objective of the study is to evaluate the safety, tolerability,...
Status
Not Yet Recruiting
Location
Peking University Cancer Hospital and Institute
Start Date
2024-11-01
Trial ID
NCT06614751
Treatments Being Tested
The purpose of this study is to test the safety of a study drug called PARP...
Status
Active Not Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2018-08-10
Trial ID
NCT03631017
Treatments Being Tested
This is a Phase 3, randomized, multinational, double-blind, dual placebo-co...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2018-05-14
Trial ID
NCT03522246
Treatments Being Tested
This is an open-label, multicenter, phase Ib/II study of the combination of...
Status
Terminated
Location
Huntsman Cancer Institute at the University of Utah
Start Date
2022-09-23
Trial ID
NCT05405309
This study aims to carry out a multi-center, randomized controlled study on...
Status
Recruiting
Location
Women's Hospital, Zhejiang University School of Medicine
Start Date
2021-05-01
Trial ID
NCT05607329
Treatments Being Tested
This is a two-part open label, non-randomized, Phase 2, study of ZEN003694 ...
Status
Terminated
Location
Banner MD Anderson Cancer Center
Start Date
2019-06-26
Trial ID
NCT03901469
Treatments Being Tested
The purpose of this study is to assess the efficacy, safety, and pharmacoki...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-31
Trial ID
NCT02854436
Treatments Being Tested
The purpose of the ATLAS study is to determine how patients with locally ad...
Status
Terminated
Location
Pinnacle Oncology, Honor Health
Start Date
2018-06-01
Trial ID
NCT03397394
Treatments Being Tested
Background: \- The new drug BMN 673 (talazoparib) has been shown to fight ...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2015-03-02
Trial ID
NCT02326844
Treatments Being Tested